Charles Schwab Stock Surges on Blowout Q3 Results, Analysts Eye More Upside

Charles Schwab Stock Surges on Blowout Q3 Results, Analysts Eye More Upside

  • Q3 beat: Schwab reported record Q3 results on Oct. 16, with net revenue $6.14 billion (up 27% YoY) and adjusted EPS of $1.31 (versus ~$1.25 expected) [1] [2]. Net income was $2.36 billion (67% YoY growth) [3]. Management highlighted “client-driven growth” – total client assets hit $11.59 trillion (up 17% YoY) and core net new asset inflows were $137.5 billion [4]. New brokerage accounts topped 1 million (4th straight quarter) [5].
  • Stock action: SCHW shares jumped after hours. The stock closed around $94 on Oct 15 [6] and traded near $98 pre-market Oct 16 on the earnings beat [7]. (One-year range is $65.88–$99.59 [8].) Year-to-date the stock is well above last winter’s lows. Schwab also buys back stock ($20 billion authorized in July [9], $2.7 billion repurchased in Q3 [10]) and pays a $0.27 quarterly dividend ($1.08 annual, ~1.1% yield) [11].
  • Analysts bullish: Before the report analysts had forecast ~$1.25 EPS on $6.02B revenue [12], so the beat is significant. Major brokerages range from Neutral to Bullish: BMO Capital initiated an Outperform (Buy) on SCHW with a $110 12‑month target [13]; Morgan Stanley reiterates an Overweight with ~$130 target [14]; Barclays just hiked its target to $114 [15]. In short, price targets span roughly $110–$130 [16], reflecting confidence in Schwab’s “bank-lite” model.
  • Peer and macro context: Competitors also posted strong results. Morgan Stanley’s wealth-management arm saw revenue of $8.2B (+13% YoY) in Q3 [17], and Interactive Brokers’ customer assets jumped 40% YoY [18]. (Robinhood and other retail brokers have also rallied on booming trading activity.) At the same time, Fed Chair Powell’s Oct.14 speech spurred a bond rally – the 10-year U.S. yield fell toward ~4.02% [19] – a positive for banks/brokers. Charles Schwab strategist Collin Martin notes long-term yields “can still hold above 4%” even if the Fed cuts rates [20], which could help Schwab’s net interest income.
  • Outlook: Analysts expect Schwab’s momentum to continue. Consensus Q4 2025 estimates are roughly $6.18B revenue and $1.28 EPS [21] (versus Q4 2024’s $4.47B/$0.87). Schwab will hold a Fall Business Update on Oct.16 with CEO Rick Wurster [22], where management will discuss strategy. Industry forecasts remain broadly positive – for example, Wall Street firms have lifted their S&P 500 year-end targets (citing dovish policy and resilient earnings) [23]. If Schwab sustains its client growth and manages expenses, many experts say more upside is likely.

Schwab’s Q3 results illustrate a strong growth cycle: client assets are growing at a record pace and fee & trading revenues are robust. As Wurster put it, this reflects “strengthening organic growth trends” and “favorable macroeconomic tailwinds” powering another “quarter of record revenue and earnings per share” [24]. With analysts updating ratings upward (as detailed by Benzinga and Capital.com) and the stock trading near multi-year highs, the near-term outlook for SCHW is widely seen as upbeat [25] [26]. Investors will watch closely how this wealth-gathering momentum holds up if market conditions change.

Sources: Company filings and press release (Oct. 16 2025) [27] [28]; MarketBeat and Benzinga earnings news [29] [30]; Capital.com and Reuters analysis [31] [32]; Nasdaq Earnings Calendar [33]; Schwab investor communications [34] [35].

References

1. www.chartmill.com, 2. www.benzinga.com, 3. pressroom.aboutschwab.com, 4. pressroom.aboutschwab.com, 5. pressroom.aboutschwab.com, 6. www.marketbeat.com, 7. www.chartmill.com, 8. www.marketbeat.com, 9. www.marketbeat.com, 10. pressroom.aboutschwab.com, 11. www.marketbeat.com, 12. www.benzinga.com, 13. www.benzinga.com, 14. capital.com, 15. capital.com, 16. capital.com, 17. www.reuters.com, 18. www.tradingview.com, 19. www.reuters.com, 20. ts2.tech, 21. www.chartmill.com, 22. pressroom.aboutschwab.com, 23. ts2.tech, 24. pressroom.aboutschwab.com, 25. www.benzinga.com, 26. capital.com, 27. pressroom.aboutschwab.com, 28. pressroom.aboutschwab.com, 29. www.chartmill.com, 30. www.benzinga.com, 31. capital.com, 32. www.reuters.com, 33. www.nasdaq.com, 34. pressroom.aboutschwab.com, 35. pressroom.aboutschwab.com

Stock Market Today

  • AHR Clears 12-Month Target as Shares Trade at $47.09
    November 6, 2025, 7:56 AM EST. American Healthcare REIT Inc (AHR) is trading at $47.09, above the average 12-month target of $46.67. When a stock surpasses a target, analysts often adjust their outlook; current data show a broad set of estimates for AHR. There are 12 targets contributing to the average, ranging from $37.00 to $51.00, with a standard deviation of $3.984. The crowd's consensus target sits at $46.67, inviting investors to decide whether the move signals further upside or a valuation stretch. The latest Zacks-based tally shows Strong Buy ratings at 9, Buys at 3, Hold at 1, with no Sells or Strong Sells, averaging 1.35 on a 1-5 scale. Data via Zacks Investment Research via Quandl.com.
  • AFG Crosses Above Average Analyst Target, Trades at $135.18
    November 6, 2025, 7:54 AM EST. American Financial Group Inc (AFG) moved above the calculated average 12-month target of $134.40 as it changed hands around $135.18. With the cross, analysts may re-evaluate: either downgrade, or raise targets if fundamentals justify higher upside. The consensus target comes from five Zacks-covering analysts, with a wide range-from $124.00 to $145.00 and a standard deviation of about $7.89. The takeaway: the crowd target is a starting point for investors to reassess the story rather than a guaranteed path. The latest ratings show few buys relative to holds (current average rating 2.75 on a 1-5 scale), highlighting caution despite the price move. Data sourced from Zacks via Quandl.
  • Marvell Technology MRVL Shares Jump 6.1% as Analysts Signal Mixed Outlook
    November 6, 2025, 7:52 AM EST. Marvell Technology (MRVL) rose 6.1% intraday, trading as high as $95.39 and last at $92.90, on about 17.16M shares. The stock's 50-day MA is $79.45 and 200-day MA is $72.76. Analysts are mixed but constructive: consensus Moderate Buy with an avg target near $93.06; notable targets include UBS at $105 and Oppenheimer at $115, while Morgan Stanley cut to $76. Fundamentals show EPS $0.67 on $2.01B revenue (up 57.6% YoY); net margin negative but other metrics healthy. The company pays a quarterly dividend $0.06 ($0.24 annual). Q3 2026 guidance implies EPS 0.690-0.790.
  • Dow Jones Futures Flat as Tech Rally Pauses; AI Valuations in Focus
    November 6, 2025, 7:49 AM EST. Stock futures were little changed Thursday after major indexes rebounded from a tech rout tied to AI valuations. S&P 500 and Nasdaq futures were up less than 0.1%, while Dow futures eased
  • Schwimmer urges Reeves to unleash £100bn UK stock market boom
    November 6, 2025, 7:46 AM EST. David Schwimmer, CEO of the London Stock Exchange Group, is expected to urge Chancellor Rachel Reeves to embed fresh budget incentives to spur as much as £100bn of additional investment from UK pension funds into UK equities. The letter, supported by more than 250 signatories from firms such as Mitchells & Butlers, Kier and Bakkavor, calls for a higher allocation of defined contribution schemes to domestic assets. Thinktank New Financial estimates that a 25% default fund allocation to UK investments could channel between £50bn and £100bn into the market. The move comes after Reeves's pension reforms and the planned merger of local authority funds. An LSEG spokesperson did not comment.
Auddia (AUUD) Stock Skyrockets on AI/Web3 Pivot – Microcap Audio Tech’s Big Day
Previous Story

Auddia (AUUD) Stock Skyrockets on AI/Web3 Pivot – Microcap Audio Tech’s Big Day

Volato Group (SOAR) Stock Skyrockets on Critical Minerals Pivot and Private Jet Growth
Next Story

Volato Group (SOAR) Stock Skyrockets on Critical Minerals Pivot and Private Jet Growth

Go toTop